Ritter pharmaceuticals inc (RTTR)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Dec'14
ASSETS
Current assets
Cash and cash equivalents

5,952

1,699

1,957

4,380

5,516

7,812

12,496

16,254

18,917

22,631

3,558

5,415

5,092

7,046

8,452

10,771

14,088

15,819

16,244

19,658

2,747

Accrued interest receivable

-

0

1

3

17

54

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investment in marketable securities

-

-

-

-

2,765

6,988

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

176

509

-

-

-

421

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses

-

-

771

442

442

-

465

538

177

167

260

346

149

156

246

65

144

189

303

42

57

Total current assets

6,129

2,210

2,730

4,826

8,742

15,277

12,962

16,792

19,094

22,799

3,819

5,761

5,242

7,203

8,698

10,837

14,232

16,008

16,547

19,701

2,804

Other assets
Right-of-use assets

65

93

119

146

172

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

478

478

32

22

27

22

10

10

10

10

10

10

10

10

10

10

10

10

15

10

10

Total other assets

543

571

152

169

199

22

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred offering costs

-

-

-

-

-

-

-

-

-

-

310

-

-

-

-

-

-

-

-

-

-

Deferred offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

143

Property and equipment, net

14

15

17

18

18

20

21

23

22

23

19

20

22

23

24

26

26

20

14

4

5

Total Assets

6,687

2,797

2,899

5,014

8,961

15,319

12,994

16,826

19,126

22,833

4,160

5,792

5,274

7,236

8,733

10,874

14,269

16,039

16,577

19,715

2,963

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable

1,290

1,417

2,566

2,428

2,133

4,512

2,130

1,361

640

2,237

2,745

2,091

1,634

1,896

2,870

1,802

2,128

739

836

1,389

1,083

Accrued expenses

311

179

141

292

1,814

1,407

408

534

145

454

196

675

900

1,222

907

932

204

614

296

972

168

Lease liabilities

70

100

119

116

113

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

-

-

-

-

-

13

14

14

15

15

15

15

15

14

14

12

1

1

-

1

2

Total current liabilities

1,672

1,697

2,826

2,837

4,061

5,933

2,553

1,910

801

2,707

2,957

2,782

2,550

3,133

3,792

2,747

2,333

1,354

1,133

2,363

1,254

Lease liabilities, non-current

-

-

10

40

70

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total Liabilities

-

-

2,837

2,878

4,132

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Preferred stock subject to redemption, $0.001 par value; 0 shares authorized, issued and outstanding as of December 31, 2015; 16,378,646 shares authorized, 13,399,668 shares issued and outstanding as of December 31, 2014

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

16,203

Stockholders' equity
Preferred stock, value

-

-

-

-

-

-

3,344

4,241

4,948

-

0

0

0

0

0

0

0

0

-

-

8

Common stock, $0.001 par value; 225,000,000 shares authorized, 45,713,863 and 19,108,331 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

45

19

9

9

9

6

5

5

5

4

14

14

11

11

8

8

8

8

7

7

0

Additional paid-in capital

86,729

79,885

76,122

75,228

75,105

71,505

70,665

69,597

68,716

68,323

52,302

52,099

49,853

49,559

42,809

42,468

42,139

41,759

40,296

39,124

3,399

Accumulated other comprehensive loss

-

-

-

-

1

-0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accumulated deficit

-82,000

-80,333

-79,888

-77,721

-74,906

-70,200

-63,575

-58,928

-55,344

-53,331

-51,114

-49,103

-47,140

-45,467

-37,876

-34,350

-30,211

-27,082

-24,860

-21,779

-17,904

Total stockholders' equity

5,015

1,099

62

2,135

4,828

9,386

10,440

14,916

18,325

20,125

1,202

3,009

2,724

4,103

4,941

8,126

11,936

14,684

15,444

17,352

-14,495

Total Liabilities and Stockholders' Equity

6,687

2,797

2,899

5,014

8,961

15,319

12,994

16,826

19,126

22,833

4,160

5,792

5,274

7,236

8,733

10,874

14,269

16,039

16,577

19,715

2,963

Series A Preferred Stock [Member]
Preferred stock, value

-

-

-

-

-

2,289

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Preferred stock, value

-

-

2,289

2,289

2,289

-

-

-

-

5,128

-

-

-

-

-

-

-

-

-

-

-

Total stockholders' equity

-

-

-

-

-

2,289

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series B Preferred Stock [Member]
Preferred stock, value

-

1,288

-

-

-

3,906

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Preferred stock, value

-

-

1,288

2,090

2,090

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total stockholders' equity

-

1,288

-

-

-

3,906

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series C Preferred Stock [Member]
Preferred stock, value

240

240

-

-

-

1,880

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Preferred stock, value

-

-

240

240

240

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total stockholders' equity

240

240

-

-

-

1,880

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-